scholarly article | Q13442814 |
P50 | author | Joseph Loscalzo | Q64498968 |
P2093 | author name string | Jane A Leopold | |
Reiko Matsui | |||
Richard A Cohen | |||
Shanqin Xu | |||
Diane E Handy | |||
Karlene A Maitland | |||
Roberto Mastroianni | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Glucose | Q37525 |
glycobiology | Q899224 | ||
atherosclerosis | Q12252367 | ||
glucose-6-phosphate dehydrogenase deficiency | Q848343 | ||
P304 | page(s) | 910-916 | |
P577 | publication date | 2006-01-26 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice | |
P478 | volume | 26 |
Q35116630 | Angiotensin II modulates interleukin-1β-induced inflammatory gene expression in vascular smooth muscle cells via interfering with ERK-NF-κB crosstalk |
Q36199128 | Diabetic vascular disease and the potential role of macrophage glucose metabolism |
Q36312427 | Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets |
Q27005605 | G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications |
Q33792893 | Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure |
Q46661376 | Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease |
Q39677440 | Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction |
Q38203616 | Glucose-6-phosphate dehydrogenase--beyond the realm of red cell biology |
Q36876510 | Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases |
Q33890987 | High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis |
Q34217495 | Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase |
Q34317717 | Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease |
Q37510093 | Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage |
Q36955142 | Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway |
Q54506443 | Influence of dietary phytosterols and phytostanols on diastolic blood pressure and the expression of blood pressure regulatory genes in SHRSP and WKY inbred rats. |
Q50522917 | Is glucose-6-phosphate dehydrogenase deficiency a risk factor for hyperbaric oxygen exposure? |
Q38644325 | Macrophage metabolism in atherosclerosis |
Q38125279 | Molecular biology of atherosclerosis |
Q41883018 | Perturbation of human coronary artery endothelial cell redox state and NADPH generation by methylglyoxal |
Q24300293 | Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects |
Q88487528 | Reactive Oxygen Species in Metabolic and Inflammatory Signaling |
Q91778990 | Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation |
Q24295960 | Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress |
Q34180238 | Stamp2 controls macrophage inflammation through nicotinamide adenine dinucleotide phosphate homeostasis and protects against atherosclerosis. |
Q34055110 | Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications |
Q89996630 | The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer |
Q91728797 | The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration |
Q38967640 | What has passed is prolog: new cellular and physiological roles of G6PD. |
Search more.